March 11, 2016  


The 2nd annual Pfizer ASPIRE Cardiovascular Grants Program offers individual grants from a total fund of US $2 million - last chance to apply!

Are you or any of your collaborators involved in PCSK9-related research and looking for funding to support your work?

See below for further details on ASPIRE Cardiovascular, a Pfizer-supported independent competitive grants program awarding individual grants of up to US $200,000 from a total fund of US $2 million to support projects which bring new insights or advance the understanding of the role of the PCSK9 protein/gene in health and disease.

Read more about the The 2nd Annual ASPIRE Cardiovascular Competitive Research Grants Program,  application deadline: March 13, 2016 >>

Welcome to the 39th Annual Scientific Meeting of the European Lipoprotein Club (ELC)

Abstract submission deadline May 01, 2016

The 39th ELC meeting will be held at the Evangelishe Akademie in Tutzing, Germany, from September 05-08, 2016. The deadline for abstract submission is May 01, 2016. Please visit the ELC website for general information on the meeting, the invited speakers for 2016, the application procedure and travel information.

Please note that the meeting was oversubscribed last year – make sure you submit your abstract before May 01, 2016, to have the chance to attend this year's meeting.

39th ELC Scientific meeting >>
Directly to the abstract submission >>

Video commentaries at Univadis®

EAS regularly publish articles, commentaries and video commentaries at Univadis®, "Atherosclerosis Global Academy", an online resource for healthcare professionals.

The EAS Univadis video commentatires have thousands of viewers every month from all over Europe  -  do not miss the latest video commentaries by Professor Philippe Moulin, Lyon, France.

Video: The clinical importance of phospholipid species >>

Find out more

About this email


European Atherosclerosis Society © 2016

This email was sent to '@@email@@' from European Atherosclerosis Society.
If you wish to stop receiving email from us, you can simply remove yourself by visiting: @@unsubscribe_url@@